Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation Strategic leadership additions position company to unlock growth and speed customer success GlobeNewswire November 17, 2025 SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Rackspace Technology(R) (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, […]

Avocado Oil Market Size to Exceed USD 1,315.84 Million by 2034 | Towards FnB According to Towards FnB, the global avocado oil market size is evaluated at USD 686.32 million in 2025 and is expected to hit USD 1,315.84 million by 2034, reflecting at a CAGR of 7.5% from 2025 to 2034. The market has

Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings GlobeNewswire November 17, 2025 Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment on Phase 2b/3 trial

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD GlobeNewswire November 17, 2025 SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., today announced the recent publication of three peer-reviewed articles evaluating the efficacy and safety of adjunctive cenobamate in adult Asian patients with uncontrolled focal seizures. The articles are based on findings from

Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, delivered the large car ferry KEYAKI, produced for Shin Nihonkai Ferry Co., Ltd. and Japan Railway Construction, Transport and Technology Agency (JRTT), at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works in Yamaguchi Prefecture on the 11th. The new ferry will

(NasdaqGM:NRXP), NRx has refiled its Abbreviated New Drug Application for KETAFREE(TM) (preservative free ketamine), received supportive correspondence from FDA, and expects Q2 2026 GDUFA date. HOPE Therapeutics is now operating three revenue-generating facilities in Florida and expects six or more by year-end providing neuroplastic drugs, transcranial magnetic stimulation, hyperbaric therapy, and digital therapeutics to treat

LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) — Vasinova, a new fashion brand rooted in Classic Americana, will debut its first capsule this November. The launch begins with timeless outerwear and handcrafted accessories created from the highest quality natural materials. Co-founded by actress Danielle Vasinova, the brand draws from her upbringing on a farm, lifelong

— West African airline will purchase nine 737-8 jets for regional, international expansion — Air Senegal to place first Boeing order in more than 20 years Boeing [NYSE: BA] and Air Senegal announced today the West African carrier has committed to order nine 737 MAX airplanes. When final, the 737 MAX order will be the

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 17, 2025 NRx has refiled its Abbreviated New Drug Application for KETAFREE(TM) (preservative free ketamine), received supportive correspondence from FDA, and expects Q2 2026 GDUFA date. HOPE Therapeutics is now operating three revenue-generating facilities in Florida and expects six